Disclosures for "PINK1 Parkinson’s Disease in New Zealand: An Overview"
-
Dr. Donnelly has nothing to disclose.
-
The institution of Dr. Buchanan has received research support from Health Research Council. Dr. Buchanan has received personal compensation in the range of $0-$499 for serving as a Enroll-HD Investigator Meeting Attendee with CHDI. Dr. Buchanan has a non-compensated relationship as a Awards Committee Member with Neurological Foundation New Zealand that is relevant to AAN interests or activities.
-
Dr. Patel has nothing to disclose.
-
Mr. Vailahi has nothing to disclose.
-
Prof. Viali has nothing to disclose.
-
Dr. Puliuvea has nothing to disclose.
-
Dr. Dayal has nothing to disclose.
-
Dr. Roxburgh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Roxburgh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CHDI. The institution of Dr. Roxburgh has received research support from Biogen. The institution of Dr. Roxburgh has received research support from Roche.